| Serial Number | 79392046 |
| Word Mark | ACELLYTRON |
| Filing Date | Tuesday, November 28, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 17, 2025 |
| Registration Number | 7830495 |
| Registration Date | Tuesday, June 17, 2025 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 29, 2025 |
| Goods and Services | Chemical-pharmaceutical preparations for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; biochemical medicines for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; vaccine preparations; influenza vaccine; chemotherapeutics; stem cells for medical purposes; medicines for human purposes for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; drugs for medical purposes, namely medicines for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; pharmaceutical preparations for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; drugs for treatment of cancer; medical preparation for treating diseases and disorders related to the immune system; biological agent, namely biologic preparations for treating cancer; pharmaceutical preparations for the prevention and treatment of cancer; living cells for medical use; oncolytic viral therapies; medical cell inhibitor, namely protein, antibody and small molecule inhibitor; reagents for medical purposes; anticancer agent; diagnostic reagents for medical purposes; pharmaceutical preparations, namely tumor suppressor; cells for medical use; dietetic food and substances adapted for medical use; biological preparations for veterinary purposes for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease |
| Goods and Services | Online advertising on a computer network; advertising services; publicity agents; dissemination of advertising and advertising matter in the nature of flyers, prospectuses, brochures, leaflets and samples; providing commercial information and advice for consumers in the choice of products and services; organization of exhibitions and trade fairs for commercial or advertising purposes; import-export agency services; marketing; sponsorship search; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies |
| Goods and Services | Preparation of prescriptions by pharmacists; stem cell therapy services; medical clinic services; providing medical information; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; health care; medical assistance |
| Goods and Services | Research and development of new products for others; technological research in the field of pharmaceutical studies, cell separation and cell culture; chemical analysis; biochemistry research and analysis; research and development in the field of pharmaceutical preparations; medical research service; research and development services in the field of antibodies; stem cell research services; medical research; medical and scientific research, namely conducting clinical trials for others; biological research; computer programming in the field of medical aspects |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 23, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 23, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 23, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Wuxi Biologics (Shanghai) Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | Wuxi Biologics (Shanghai) Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | Wuxi Biologics (Shanghai) Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Event Date | Event Description |
| Saturday, March 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 27, 2024 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, June 26, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, March 21, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, October 10, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 26, 2024 | ASSIGNED TO EXAMINER |
| Thursday, June 27, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, July 18, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, July 18, 2024 | REFUSAL PROCESSED BY MPU |
| Sunday, August 11, 2024 | REFUSAL PROCESSED BY IB |
| Thursday, October 10, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 10, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 13, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, January 13, 2025 | FINAL REFUSAL E-MAILED |
| Friday, February 21, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 1, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, January 13, 2025 | FINAL REFUSAL WRITTEN |
| Friday, February 21, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 21, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, April 29, 2025 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 23, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 29, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 17, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 17, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, August 20, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Friday, September 5, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, September 17, 2025 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Wednesday, August 20, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |